Find out more about Ian Kronborg's experience
Ian Kronborg's highlights
Ian Kronborg's selected work
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people wi..
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective po..
Liver stiffness measurement in the primary care setting detects high rates of advanced fib..
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection..
Displaying the 18 most recent scholarly works by Ian Kronborg.
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
Jason Grebely, Brian Conway, Evan B Cunningham, Chris Fraser, Alberto Moriggia, Ed Gane, Catherine Stedman, Curtis Cooper, Erika Castro, Patrick Schmid, Kathy Petoumenos, Behzad Hajarizadeh, Phillipa Marks, Amanda Erratt, Olav Dalgard, Karine Lacombe, Jordan J Feld, Julie Bruneau, Jean-Pierre Daulouede, Jeff Powis, et al.
Journal article | 2018 | International Journal of Drug Policy
BACKGROUND: Direct-acting antiviral therapy for hepatitis C virus (HCV) infection is safe and effective, but there are little data..
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study
Thai P Hong, Paul J Gow, Michael Fink, Anouk Dev, Stuart K Roberts, Amanda Nicoll, John S Lubel, Ian Kronborg, Niranjan Arachchi, Marno Ryan, William W Kemp, Virginia Knight, Vijaya Sundararajan, Paul Desmond, Alexander J Thompson, Sally J Bell
Journal article | 2018 | Medical Journal of Australia
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C
Stephen Bloom, William Kemp, Amanda Nicoll, Stuart K Roberts, Paul Gow, Anouk Dev, Sally Bell, Siddharth Sood, Ian Kronborg, Virginia Knight, Diana Lewis, John Lubel
Journal article | 2018 | Journal of Hepatology
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
Emily K Wright, Michael A Kamm, Peter De Cruz, Amy L Hamilton, Fabiyola Selvaraj, Fred Princen, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian C Lawrance, Jane M Andrews, Peter A Bampton, Simon L Jakobovits, Timothy H Florin, Peter R Gibson, Henry Debinski, Finlay A Macrae, Douglas Samuel, Ian Kronborg, Graham Radford-Smith, et al.
Journal article | 2018 | Journal of Crohn's and Colitis
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Jason Grebely, Olav Dalgard, Brian Conway, Evan B Cunningham, Philip Bruggmann, Behzad Hajarizadeh, Janaki Amin, Julie Bruneau, Margaret Hellard, Alain H Litwin, Philippa Marks, Sophie Quiene, Sharmila Siriragavan, Tanya L Applegate, Tracy Swan, Jude Byrne, Melanie Lacalamita, Adrian Dunlop, Gail V Matthews, Jeff Powis, et al.
Journal article | 2018 | The Lancet Gastroenterology & Hepatology
BACKGROUND: Despite revised guidelines that no longer exclude people who inject drugs (PWID) from treatment for hepatitis C virus ..
Serologic antibodies in relation to outcome in postoperative Crohn's disease
Amy L Hamilton, Michael A Kamm, Peter De Cruz, Emily K Wright, Fabiyola Selvaraj, Fred Princen, Alexandra Gorelik, Danny Liew, Ian C Lawrance, Jane M Andrews, Peter A Bampton, Miles P Sparrow, Timothy H Florin, Peter R Gibson, Henry Debinski, Richard B Gearry, Finlay A Macrae, Rupert W Leong, Ian Kronborg, Graham Radford-Smith, et al.
Journal article | 2017 | Journal of gastroenterology and hepatology
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study
Adam Doyle, Philip Marsh, Raghubinder Gill, Marcia Rodov, Waled Mohsen, Poornima Varma, Thai Hong, Simone I Strasser, Sally Bell, Marno Ryan, Amanda Nicoll, John Lubel, Paul J Gow, Michael Anthony Fink, Stuart Roberts, William Kemp, Ian Kronborg, Niranjan Arachchi, Virginia Knight, Anouk Dev
Journal article | 2016 | Scandinavian Journal of Gastroenterology
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies
Stuart K Roberts, Joanne Mitchell, Reynold Leung, David Booth, Steven Bollipo, George Ostapowicz, Andrew Sloss, Geoffrey W McCaughan, Gregory J Dore, Alexander Thompson, Darrell HG Crawford, William Sievert, Martin Weltman, Wendy Cheng, Jacob George
Journal article | 2014 | Journal of Gastroenterology and Hepatology
Hepatic macrophage activation predicts clinical decompensation in chronic liver disease
Anthony Rode, Amanda Nicoll, Holger Jon Moller, Lucy Lim, Peter W Angus, Ian Kronborg, Niranjan Arachchi, Alexandra Gorelik, Danny Liew, Konstantin Kazankov, Hendrik Vilstrup, Henning Gronbaek
Journal article | 2013 | Gut
Honours, Awards and Fellowships
FRACP - Fellow of the Royal Australasian College of Physicians
Bachelor of Medicine & Bachelor of Surgery
Institution not known